Submission Details
| 510(k) Number | K111217 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2011 |
| Decision Date | June 14, 2011 |
| Days to Decision | 43 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K111217 is an FDA 510(k) clearance for the ADDITIVE CAP, a Container, I.v. (Class II — Special Controls, product code KPE), submitted by Baxter Healthcare Corp (Mcgaw Park, US). The FDA issued a Cleared decision on June 14, 2011, 43 days after receiving the submission on May 2, 2011. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5025.
| 510(k) Number | K111217 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2011 |
| Decision Date | June 14, 2011 |
| Days to Decision | 43 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | KPE — Container, I.v. |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5025 |